Photo: Myboys.me/Shutterstock
Brazilian health regulator Anvisa will no longer require vaccines used by the UN-backed COVAX facility to file requests for emergency approval. Brazil is expected to receive 10.6 million of the 42 million doses it is entitled to in the first half of the year, mainly from AstraZeneca.
The decision may help speed up the immunization process, as India’s Serum Institute — which has provided the first 2 million doses of the AstraZeneca vaccine — would otherwise have to file for emergency use requests in Brazil.
Support this coverage →Brazil’s National Institute for Space Research (Inpe) revealed on Wednesday consolidated data showing a 21.8…
Eve Air Mobility, a startup spun off Embraer’s innovation arm Embraer-X years ago, unveiled a…
Weather forecasts from the south indicate that the climate emergency in Rio Grande do Sul…
Brazil's southernmost state is underwater after days of severe heavy rains, with the human and…
Residents complain that the official response to catastrophic floods in Rio Grande do Sul state…
Congress enacted a state of calamity that will be valid through the end of the…